Hi,
A new rating for API from RBS, as upgrade to Buy. The broker notes a new Community Pharmacy Agreement is set to come into effect on July 1 next year, with the focus likely to be on an increase in the use of generics and improved transparency in mark-up pricing on drugs.
Target price is $0.86! is this the explanation for all the action today?
seems the dumping has finished, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
